inovio pharmaceuticals inc
(INO:NYSE Amex)
Executive Profile*
Niranjan Y. Sardesei Ph.D.Chief Operating Officer, Inovio Pharmaceuticals, Inc. |
| Age | Total Calculated Compensation | This person is connected to 0 board members in 0 different organizations across 3 different industries. |
| 44 | $475,308 As of Fiscal Year 2012 |
Background*
Dr. Niranjan Y. Sardesai, PhD has been the Chief Operating Officer of Inovio Pharmaceuticals Inc since January 2012. Dr. Sardesai served as a Senior Vice President of Research & Development at Inovio Biomedical Corporation. from June 1, 2009 to December 2011. Dr. Sardesai served as Senior Vice President of Research & Development of VGX Pharmaceuticals, LLC from November 2007 to June 1, 2009. Dr. Sardesai served as Vice President of Product Development at VGX Pharmaceuticals, ...
Corporate Headquarters*Building 18Blue Bell, Pennsylvania 19422 United States Phone: 267-440-4200 Fax: 267-440-4242 Board Members Memberships*There is no Board Members Memberships data available.Education*PhD California Institute of Technology MBA University of Pennsylvania - The Wharton School MS IIT Council BS Indian Institute of Technology, Bombay
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| INO:US | $0.71 USD | +0.02 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Vijay B. Samant | Chief Executive Officer, President, Acting Chief Financial Officer and Director Vical Incorporated | $864.8K |
| Mark R. Baker J.D. | Chief Executive Officer, Director, Member of Science & Technology Committee and Member of Strategy & External Technology Subcommittee Progenics Pharmaceuticals, Inc. | $672.8K |
| Garo H. Armen Ph.D. | Founder, Executive Chairman, Chief Executive Officer and President Agenus Inc. | $478.1K |
| Stephen M. Simes | Vice Chairman, Chief Executive Officer and President BioSante Pharmaceuticals, Inc. | $496.7K |
| Anthony S. Marucci M.B.A. | Chief Executive Officer, President and Director Celldex Therapeutics, Inc. | $769.5K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact INOVIO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
